Skip to main content

Drug Recalls

Featured Article
A prescription ophthalmic solution used to reduce pressure inside the eye from glaucoma is being recalled.
Two more firms have announced voluntary recalls of ranitidine products due to contamination with the probable human carcinogen NDMA.


Older patients account for about a third of all inpatient care, but they are involved in approximately half of hospitalizations marred by adverse drug events.

Interactive Features

Peter Pitts, former associate commissioner at the US FDA and president of the Center for Medicine in the Public Interest, discusses why the FDA pulled a large quantity of a blood pressure drugs off the market and why it is important to understand.…
Back to Top